Fulgent Genetics Expands into Houston
Fulgent Houston will focus on covid-19 testing initially, with capacity for 20,000 tests per day and the ability to expand as demand continues to increase.
Read MorePosted by Melanie Hamilton-Basich | Aug 28, 2020 | Company News, Covid 19 |
Fulgent Houston will focus on covid-19 testing initially, with capacity for 20,000 tests per day and the ability to expand as demand continues to increase.
Read MorePosted by Melanie Hamilton-Basich | Aug 25, 2020 | Covid 19 |
The P-Best covid-19 pooling test algorithm identified all positive subjects, including asymptomatic carriers, in a single round of testing.
Read MorePosted by Melanie Hamilton-Basich | Aug 21, 2020 | Cancer, Molecular Diagnostics |
The Oncomine Myeloid Assay GX is the first in a series of clinical research assays available from the new hematology-oncology portfolio.
Read MorePosted by Melanie Hamilton-Basich | Aug 17, 2020 | Colorectal |
A new study comparing four CRC screening alternatives found that annual colorectal cancer screening with Epi proColon was cost effective.
Read MorePosted by Melanie Hamilton-Basich | Aug 16, 2020 | Company News, Covid 19 |
ELITechGroup has distributed more than 3.5 million covid-19 tests worldwide and installed more than 500 of its ELITe InGenius PCR system globally.
Read More